Japan-based Global Health Innovative Technology Fund invests US$7 million to combat tuberculosis, Chagas disease, malaria

The Global Health Innovative Technology Fund (GHIT), a Japan-based international private-public partnership, announced that it will provide about ¥750 million (US$7 million) to develop six projects focused on combating tuberculosis, Chagas disease, and malaria. The projects include a novel diagnostic tool for tuberculosis, a vaccine for malaria in pregnant women, the discovery of new modalities for malarial vaccine development, and the screening of chemical libraries for drug discovery in Chagas disease.

As of November 4, 2021, GHIT is funding 63 projects; 29 projects are in discovery stages, 24 in preclinical studies, and 10 in clinical trials.

Press release - Global Health Innovative Technology Fund